NASDAQ: VCYT
Veracyte Inc Stock Ownership - Who owns Veracyte?

Insider buying vs selling

Have Veracyte Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Karin EasthamDirector2026-06-183,200$52.78
$168.91kSell
Karin EasthamDirector2026-06-18529$53.55
$28.33kSell
Marc StapleyChief Executive Officer2026-06-04138,051$50.12
$6.92MSell
Rebecca ChambersChief Financial Officer2026-06-041,600$49.28
$78.85kSell
Rebecca ChambersChief Financial Officer2026-06-041,961$50.09
$98.23kSell
Marc StapleyChief Executive Officer2026-06-04138,051$36.60
$5.05MBuy
John LeiteGlobal Chief Commercial Off2026-06-0413,975$50.07
$699.73kSell
Annie McGuireEVP General Counsel2026-06-041,776$50.12
$89.01kSell
Annie McGuireEVP General Counsel2026-06-041,400$49.31
$69.03kSell
Jonathan WygantVP Chief Accounting Officer2026-06-021,361$47.80
$65.06kSell

1 of 10

VCYT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VCYT insiders and whales buy or sell their stock.

VCYT Shareholders

What type of owners hold Veracyte Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc16.51%13,172,618$610.16MInstitution
Fmr LLC9.73%7,763,849$359.62MInstitution
Artisan Partners Limited Partnership6.89%5,496,370$254.59MInstitution
State Street Corp6.32%5,043,590$233.62MInstitution
Vanguard Portfolio Management LLC5.57%4,444,730$205.88MInstitution
Brian G. Atwood4.53%3,616,221$167.50MInsider
Versant Ventures III LLC4.53%3,616,221$167.50MInsider
Samuel D. Colella4.53%3,616,221$167.50MInsider
Tpg Group Holdings Sbs Advisors Inc4.45%3,551,929$164.53MInsider
Brook H. Byers4.45%3,551,929$164.53MInsider

1 of 3

VCYT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VCYT67.25%32.75%Net SellingNet Selling
VKTX62.74%8.90%Net SellingNet Selling
DNLI62.37%37.63%Net Selling
ADPT63.49%36.51%Net SellingNet Selling
RLAY79.47%20.53%Net SellingNet Selling

Veracyte Stock Ownership FAQ

Who owns Veracyte?

Veracyte (NASDAQ: VCYT) is owned by 110.64% institutional shareholders, 53.89% Veracyte insiders, and 0.00% retail investors. Brian G. Atwood is the largest individual Veracyte shareholder, owning 3.62M shares representing 4.53% of the company. Brian G. Atwood's Veracyte shares are currently valued at $167.50M.

If you're new to stock investing, here's how to buy Veracyte stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.